Search
Fractyl Health Inc
GUTSAdd to Watchlist
0.762USD
-0.021-2.62%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
120.89MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of Fractyl Health Inc is 8.40, ranking 128 out of 387 in the Biotechnology & Medical Research industry. The average price target is 8.00, with a high of 10.00 and a low of 5.00.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
5.240
Target Price
+558.62%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Fractyl Health Inc
GUTS
5
Beigene Ltd
ONC
27
Ionis Pharmaceuticals Inc
IONS
27
CRISPR Therapeutics AG
CRSP
26
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Fractyl Health Inc's price target?
Analysts forecast that Fractyl Health Inc's price target is USD 8.00, with the highest forecast at USD 10.00 and the lowest forecast at USD 5.00.
How have Fractyl Health IncGUTS's recent earnings per share performed?
The market expectation was USD 0.06, while Fractyl Health IncGUTS's earnings per share (EPS) for the previous quarter was USD -0.31. EPS for the next quarter is expected at USD -0.14.
What is the analyst rating for Fractyl Health Inc?
Based on the ratings of Fractyl Health Inc's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.